Tacrolimus 1 MG capsule (IR) 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3JY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,059
Award facts
- Contract value 100% obligated
- $1,059.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,059.15 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units. The contract was awarded on January 28, 2026, with an ultimate completion date of January 29, 2026, and carries a firm fixed-price structure with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999.99 million through December 31, 2031, serving as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of medications and medical commodities to military and veteran healthcare systems through competitive federal contracting. Tacrolimus, an immunosuppressant medication commonly used in transplant patients and certain autoimmune conditions, represents one of many pharmaceutical products the company routinely delivers to federal agencies. The non-set-aside competitive award demonstrates AmerisourceBergen's capability to meet DLA requirements through open competition, consistent with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM3JY?
SPE2DR26FM3JY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FM3JY worth?
The government has obligated $1,059 on SPE2DR26FM3JY.
Is contract SPE2DR26FM3JY an order under another contract?
Yes. SPE2DR26FM3JY is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3JY competed?
The extent of competition for SPE2DR26FM3JY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award